Canadian Health Minister, Tony Clement, announced yesterday that Canada has signed a 10-year agreement with Glaxo-Smith Kline (GSK) to ensure Canada receives anti-pandemic vaccine in the event of an influenza pandemic. This agreement is contingent on a $199 million Canadian investment to double the capacity of GSK vaccine plants in Quebec City, allowing GSK to produce up to 225 million doses of an anti-pandemic vaccine.
Full story available online via the National Post:
http://www.canada.com/nationalpost/news/story.html?id=6033fffe-9783-422b-a31c-5d7ff583a664&k=19352
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment